Results 181 to 190 of about 2,264,386 (292)
Molecular Oncology, EarlyView.Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed +8 more
wiley +1 more source
Physical chemistry for the life sciences (Barrow, Gordon M.)
, 1975 Scott L. Kittsley
openalex +1 more source
Experiences from a life sciences laboratory: Using a paired-associates task as a teaching heuristic for programming instruction [PDF]
, 1987 J. W. Whitlow
openalex +1 more source
Citation Contamination by Paper Mill Articles in Systematic Reviews of the Life Sciences.
JAMA Netw OpenTang G, Cai H.
europepmc +1 more source
Molecular Oncology, EarlyView.Loss of primary cilia in endothelial cells promotes EndMT and vascular abnormalities in the ovarian tumor microenvironment through EphA2 activation. Using human samples, in vitro models, and endothelial‐specific Kif3a‐knockout mice, we show that primary cilia loss drives the acquisition of cancer‐associated fibroblast‐like phenotypes, thereby ...
Jin Gu Cho +11 more
wiley +1 more source
Negotiating an academic start-up package and job offer as an incoming tenure-track professor in the life sciences. [PDF]
BMC ProcCaromile LA, Segarra VA.
europepmc +1 more source
Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma
Molecular Oncology, EarlyView.GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski +19 more
wiley +1 more source